Author: URP Admin

The University of Wisconsin–Madison has joined a statewide consortium of 15 public and private partners, mobilizing its experience and expertise as a collaborative powerhouse in bioscience and technology to help bolster Wisconsin’s leadership in personalized medicine and biohealth technology....

Cellular therapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy and stem cell therapy, are promising new avenues in cancer treatment and regenerative medicine. Many of these therapies are still in their infancy, requiring further development to increase efficacy and accessibility....